Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap

NCT03263130 is registered in ClinicalTrials.gov with Gelb, Arthur F., M.D. as lead sponsor.

NCT NCT03263130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03263130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
Lead sponsor
Gelb, Arthur F., M.D.
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2017
Completion date
December 1, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

copd, emphysema, asthma copd overlap, emphysema